The more than $1B for COVID-19 research includes $40M to do viral sequencing and $600M for private sector trials of drug treatments and vaccines.
The more than $1B for COVID-19 research includes $40M to do viral sequencing and $600M for private sector trials of drug treatments and vaccines.